Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03298308
Other study ID # 418467-1
Secondary ID
Status Completed
Phase N/A
First received September 20, 2017
Last updated September 26, 2017
Start date May 27, 2016
Est. completion date May 10, 2017

Study information

Verified date September 2017
Source Walter Reed National Military Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study explored relationships between cranial electric stimulation and brainwave changes.


Description:

This pilot study will collect data from properly consented and subsequently enrolled subjects in the Psychiatric Continuity Service (PCS). All PCS programs provide both group and individual therapy designed to address various chronic mental health disorders such as major depressive disorder, anxiety, and post-traumatic stress disorder (PTSD). Group therapy and education focus on how chronic mental health disorders develop, the recovery process and psychosocial stressors that may contribute to both improvement in functioning and declines. Every patient is different with regard to how his or her program is tailored, but everyone receives weekly individual counseling from behavioral health providers (psychiatrists, psychologists and clinical social workers). PCS works in tandem with other treatment providers, case managers and chains of command. PCS is also equipped to transfer patients in need to higher levels of care in cases of emergency.

All prospective subjects will be active duty service members who are enrolled in PCS. Subjects will be recruited by the Associate Investigator (AI) or Principal Investigator (PI). The primary outcome measure is the exploration of changes in specific brain wave activity in response to a Cranial Electrotherapy Stimulation (CES) intervention.

Subjects who agree to participate in the study will complete a consent and Health Insurance Portability and Accountability Act (HIPAA) form and baseline questionnaires. In addition, since the fetal effects of the CES device is not known;, female subjects will have to present a negative pregnancy test within one week of the research intervention. Those female subjects to which pregnancy is unlikely (i.e. hysterectomy), will be excluded from a pregnancy test if this information can be verified medically. will self-report regarding as it applies menstrual cycle length and birth control method used within the last two weeks.

The intervention will take place during clinic hours. This will be a one-time intervention that will last approximately 1 to 1 ½ hours. The AI will prepare the CES device, briefly explain the function, and place the CES ear clips on the subject. The CES device will not be turned on at this point. This is similar to clinic practice, however in clinical practice any PCS staff trained in the use of the CES device may prepare and administer the CES device to the patient.

Next the AI will prepare the MindSet EEG device, ensure that it is functioning properly, and obtain signal acquisition. The AI will then explain the brainwave headset (MindSet) to the subject and properly place the headset on their head. Next a series of computer led activities to reduce extraneous artifacts (such as eye blink and muscle movement) will be completed by the subject. Following this, a baseline test measuring brainwave frequencies will be completed by the subject. This will last 30 seconds. Once this is completed, the CES device can be turned on and activated for 20 minutes. The CES micro amperage will be set by the subject based on therapeutic dose and locked in place on the CES device. Immediately following the completion of the 20 minute CES session, an EEG brainwave measure will be completed. Additional brainwave measure will be taken 5 minutes and 10 minutes post the CES session. Each of these brainwave measures will last 30 seconds.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 10, 2017
Est. primary completion date May 10, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Inclusion Criteria All prospective subjects will be active duty service members who are enrolled in PCS

Exclusion Criteria:

- • Subjects will be excluded who have a seizure disorder, a cardiac pacemaker, or active untreated vertigo.

- Subjects will be excluded if they have used CES the day of the study. However, they may participate in the study the following day.

- Female subjects who are or who suspect they may be pregnant.

- Subjects will also be excluded who are clinically judged by the investigators to be actively suicidal or have another psychiatric condition that would require inpatient hospitalization

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cranial Electric Stimulation
Micro amperage TCDS

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Walter Reed National Military Medical Center

Outcome

Type Measure Description Time frame Safety issue
Primary Quantitative EEG Analysis The investigators used a commercially available EEG headset (Neurosky MindSet) in combination with EEG software (SmartMind) to obtain and analyze the Quantitative EEG from the subjects. The combination of the EEG headset with the software identified the five brainwave frequencies that are clinically relevant in studying EEG activity: Alpha, Beta, Delta, Gamma, and Theta. The combination of the headset and software reported changes in brainwave amplitude in microvolts for each brainwave frequency. Alpha waves increase with relaxation and drowsiness; and Beta waves, increase with wakefulness and concentration. Delta and Theta waves increase during meditative states and Gamma may suggest brain synchronicity. Quantitative EEG collected at baseline (immediately before stimulation), immediately after 20 minutes of stimulation and then 5 and 10 minutes post stimualtion. Each of these four measures will record 30 seconds of brainwave activity
See also
  Status Clinical Trial Phase
Completed NCT03409991 - Testing the Efficacy of Opening Doors: A Career Guidance Intervention for Individuals With Psychiatric Disabilities N/A
Not yet recruiting NCT05316948 - Mental Health and Sexuality in Adolescents and Young Adults
Completed NCT04778163 - The Use of Humor With Young Adults in Psychiatric Care N/A
Not yet recruiting NCT06304363 - Braining - Evaluation of Acute Effects of Physical Exercise N/A
Recruiting NCT04096625 - Enhancement of a Psychotherapeutic Intervention Through Transcranial Direct Current Stimulation (tDCS) N/A
Terminated NCT06012981 - Psychological Treatment in Psychiatric Inpatient Care N/A
Not yet recruiting NCT05930353 - Psychometric Validation of a French-language Version of the PERMA-Profiler: Tools for Assessing Multidimensional Subjective Well-being
Completed NCT04099173 - A Brief Mindfulness-Based Intervention for Suicidal Ideation N/A
Completed NCT01866956 - Computerized Screening for Comorbidity in Adolescents With Substance or Psychiatric Disorders
Recruiting NCT04249960 - Sustain and Reinforce the Transition From Child to Adult Mental Health Care in Switzerland : A Monocentric Nested Cohort Randomized Controlled Trial: The SORT Study. N/A
Recruiting NCT05962424 - HNC: Human Neural Circuits Electrophysiology During Cognition Phase 1
Recruiting NCT06092866 - Digital Versus Telephone Symptom Assessment and Triage in Primary Care N/A
Recruiting NCT03678194 - Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application N/A
Completed NCT03748355 - Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects N/A
Completed NCT05473962 - Mid-Term Follow-up Assessment After Exposure to Natural Disaster
Recruiting NCT05577585 - Ketamine and Stress in OCD N/A
Completed NCT05124158 - COVID-19 Severity and Psychiatric Morbidity
Recruiting NCT05560581 - Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy N/A
Completed NCT04618250 - Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) N/A
Not yet recruiting NCT06014164 - Qualitative Study About Psychedelics Using in Psychiatric Disorders